Preferred Label : isradipine;

MeSH definition : A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.;

MeSH hyponym : PN-205-033; PN 200-110; isradipine, (R)-Isomer; PN 205-034; dynacirc; isradipine, ( -)-Isomer; isradipine, (S)-Isomer; lomir; PN 205 033; PN205033; PN 205-033; PN 205033; PN-200-110; PN 205 034; PN 205034; PN-205-034; PN205034;

MeSH CAS label : 3,5-Pyridinedicarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-, methyl 1-methylethyl ester;

MeSH Related Number : isradipine, ( -)-Isomer; isradipine, (R)-Isomer; isradipine, (S)-Isomer; 75695-93-1 (Isradipine); 84260-63-9 ((R)-isomer); 84260-64-0 ((S)-isomer); 88977-22-4 (( -)-isomer);

Registry Number MeSH : 75695-93-1;

Related CAS MeSH : 84260-64-0 (Isradipine, (S)-Isomer); 88977-22-4 (Isradipine, ( -)-Isomer); 84260-63-9 (Isradipine, (R)-Isomer);

Is substance : O;

UNII : YO1UK1S598;

InChIKey : HMJIYCCIJYRONP-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67966754
2010
France
French
capsules
Delayed-Action preparations
administration, oral
isradipine
isradipine
antihypertensive agents
antihypertensive agents
calcium channel blockers
calcium channel blockers
hypertension
adult
aged
drug interactions
pregnancy
breast feeding
isradipine
summary of product characteristics
package leaflet

---
http://www.lecrat.eu/?s=Isradipine+-+ICAZ%C2%AE
2009
France
French
isradipine
calcium channel blockers
antihypertensive agents
pregnancy
breast feeding
isradipine
drug information

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.